Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress
SGR-1505 was observed to have a favorable safety profile and was well tolerated, with encouraging preliminary efficacy in…
Browsing Tag